Awaiting the outcome of the Patient Capital Review with an eagerness that borders on, well, impatience, Ian Battersby wonders how financial advisers will be expected to embrace whatever new rules emerge
The results of the Patient Capital Review are eagerly anticipated by tax-advantaged product providers, advisers and investors alike but, at the present time, there is very little clarity about what might...
Smoking biggest culprit; obesity second
Average earner will gain £840 in 2018
Will also move heritage items
Responding to letter from Treasury Committee chair Nicky Morgan